Navigation Links
New treatment for irritability in autism
Date:5/31/2012

Philadelphia, PA, May 31, 2012 Autism is a developmental disorder that affects social and communication skills. Irritability is a symptom of autism that can complicate adjustment at home and other settings, and can manifest itself in aggression, tantrums, and self-injurious behavior. These disruptive behaviors are frequently observed in children with autism, which may considerably affect their ability to function at home or in school.

N-acetylcysteine (NAC) is approved by the US Food and Drug Administration for the treatment of acetaminophen (Tylenol) overdoses, but it may have other applications related to its effects in the brain. NAC helps maintain and restore glutathione, which play a key role in the antioxidant defense system. Additionally, cysteine as supplied by NAC treatment, stimulates a protein, the cystine-glutamate antiporter, resulting in the decrease of glutamatergic neurotransmission. NAC has two resulting effects: 1) it may protect brain cells by raising the level of a protective antioxidant metabolite called glutathione, and 2) it may reduce the excitability of the glutamate system by stimulating inhibitory receptors.

These drug actions are important because, although the causes of autism are unknown, it is clear that there are many influencing factors and scientists are pursuing multiple hypotheses. Two in particular relate to NAC: one theory is that autism may be caused by an imbalance between oxidants and antioxidants in the body; the other is that the glutamate system may be dysfunctional in individuals with autism.

These hypotheses led researchers at Stanford University and the Cleveland Clinic to conduct a pilot trial of NAC in children with autistic disorder. Children were randomized to receive either NAC or placebo daily for 12 weeks and their symptoms were evaluated four times during that period.

They found that irritability was significantly decreased in the children who received NAC. In addition
'/>"/>

Contact: Rhiannon Bugno
biol.psych@utsouthwestern.edu
214-648-0880
Elsevier
Source:Eurekalert

Page: 1 2

Related biology news :

1. The effect of treatment with antibiotics and vaccination against Q fever in sheep
2. Purdue professor to speak before Congress about nanotechnology in brain treatment research
3. Novel discovery by NUS scientists paves the way for more effective treatment of cancers
4. Discovery of mechanisms predicting response to new treatments in colon cancer
5. UH Case Medical Center, CardioKinetix reveal promising data for treatment for heart failure
6. Scripps Florida scientists awarded $8.4 million grant to develop new anti-smoking treatments
7. Scientists discover new type of cell with a key role in treatment-resistant asthma
8. From urban climate research to the treatment of incontinence
9. Sloppy shipping of human retina leads IU researchers to discover new treatment path for eye disease
10. Beehive extract shows potential as prostate cancer treatment
11. Geneticist develops tool to identify genes important in disease, tailoring individual treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... , Dec. 22, 2014 Research and Markets ... addition of the "The Global Watermarking and ... http://photos.prnewswire.com/prnh/20130307/600769 ... digital media watermarking and fingerprinting markets. Watermarking aims ...
(Date:12/19/2014)... Markets ( http://www.researchandmarkets.com/research/8kmfcn/iphone_5s ) has announced the ... Apple/AuthenTec TMDR92 & Sapphire - Technology Report" report ... Following the acquisition of AuthenTec in ... the iPhone 5S. It is currently the only device ...
(Date:12/19/2014)... MOUNTAIN VIEW, Calif. , Dec. 18, 2014  23andMe, Inc., ... a study that pinpoints fine-scale differences in genetic ancestry of ... Since immigrants first arrived more than four hundred ... served as a meeting place for peoples from different continents. ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4
... human world record for the most densely populated space and ... equivalent, the most species rich area on earth. The team,s ... reveal the record is contested between South America,s tropical rainforests ... of species in one space and the questions it raises ...
... he knows what was ailing Tiny Tim, the iconic character ... descriptions of both the symptoms and living conditions of 18th ... a combination of rickets and tuberculosis (TB). His findings ... of Pediatrics and Adolescent Medicine . Dr. ...
... a way to create temporary holes in the membranes of ... be published in JoVE, the Journal of Visualized Experiments ... for this method when we wanted to be able to ... on cells," said paper-author Dr. Delphine Dean. She said ...
Cached Biology News:European grasslands challenge rainforests as the most species-rich spaces on Earth 2Researchers print live cells with a standard inkjet printer 2
(Date:1/23/2015)... Colo. , Jan. 23, 2015  Array BioPharma Inc. ... has reached a definitive agreement with Novartis Pharma AG ... inhibitor currently in Phase 3 development.  This agreement is conditional ... GlaxoSmithKline PLC (GSK) on April 22, 2014, which are expected ...
(Date:1/22/2015)... , Jan. 22, 2015  Transwestern | RBJ today announces ... of office space for Shire a leading biopharmaceutical company, at ... Transwestern | RBJ,s Robert Richards , president, and ... lease for the entire five-floor building at 95 Hayden Ave. ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The laboratory ... that has witnessed a number of technological advancements due ... regulatory requirements, growing need to integrate healthcare systems, and ... ease challenges in system integration. Key players in the ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 zFlo Motion ... pleased to announce an exciting product from a new partner. ... analysis solutions over the past 15 years, with offerings in ... recently, their 3D IMU system (inertial measurement unit), iSen, is ...
Breaking Biology Technology:Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 2Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 3Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 4Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 5Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 6Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 7Transwestern | RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 43D Motion Capture Just Got Easy 2
... InterMune, Inc.,(Nasdaq: ITMN ) today announced that ... present at the BMO Capital Markets 2008 Focus,on Healthcare ... 10:00 a.m. EDT., To access a live audio ... log on to the investor relations page of InterMune,s,corporate ...
... Bioheart, Inc.,(Nasdaq: BHRT ) a company ... monitor, diagnose and treat heart failure and,cardiovascular diseases, ... June 30, 2008., Recent Clinical Highlights:, ... the results of a preclinical,study involving the injection ...
... ... patients into screening completed in second LymphoStat-B(R), Phase 3 trial in systemic lupus erythematosus; completion of randomization ... expected in August 2008 -, - Initial data from Phase 2 ... third quarter 2008 ...
Cached Biology Technology:Bioheart, Inc. Announces Financial Results for Second Quarter 2008 2Bioheart, Inc. Announces Financial Results for Second Quarter 2008 3Bioheart, Inc. Announces Financial Results for Second Quarter 2008 4Bioheart, Inc. Announces Financial Results for Second Quarter 2008 5Bioheart, Inc. Announces Financial Results for Second Quarter 2008 6Bioheart, Inc. Announces Financial Results for Second Quarter 2008 7Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 2Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 3Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 4Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 5Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 6Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 7Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 8Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments 9
Comp Dim: chamber diam. depth 20 2.8 mm chamber maximum volume 720 μL...
... vitro diagnostic assays, all EIA/RIA plates are ... binding, high optical clarity and low background ... of the Certified Surface Chemistry Programme, which ... QA release specifications. Linkage: This CLS number ...
... clarification reagent; Ideal for clarifying many ... proteins, nucleic acids, & proteoglycans; Contains ... improves downstream processing; Utilizes a reagent ... supplied as a suspension in saline; ...
... The lyophilization stabilizer is designed to ... and for long-term storage. There ... ingredients. It is a convenient ... 7.2, and is superior to other ...
Biology Products: